[ATYPICAL ASPECTS OF PIGMENTATION DUE TO SYNTHETIC ANTIMALARIALS (APROPOS OF 2 CASES)].
D000655:Amodiaquine; D000962:Antimalarials; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002738:Chloroquine; D002746:Chlorpromazine; D004358:Drug Therapy; D005841:Gentisates; D006486:Hemosiderosis; D006886:Hydroxychloroquine; D008548:Melanosis; D010336:Pathology; D010858:Pigmentation; D010859:Pigmentation Disorders; D014116:Toxicology
D000962:Antimalarials; D005841:Gentisates; D000655:Amodiaquine; D006886:Hydroxychloroquine; D002738:Chloroquine; D001205:Ascorbic Acid; D002746:Chlorpromazine
AMODIAQUINE; ANTIMALARIALS; ASCORBIC ACID, THERAPEUTIC; CHLOROQUINE; CHLORPROMAZINE; DRUG THERAPY; GENTISATES; HEMOSIDEROSIS; HYDROXYCHLOROQUINE; MELANOSIS; PATHOLOGY; PIGMENTATION DISORDERS; TOXICOLOGIC REPORT
ASPECTS ATYPIQUES DE PIGMENTATION DUE AUX ANTIPALUDIQUES DE SYNTH'ESE (A PROPOS DE DEUX CAS)